Form 424B3 Invesco DB US Dollar
Filed Pursuant to Rule 424(b)(3)
Registration Nos. 333-257258
333-257258-01
PROSPECTUS SUPPLEMENT NO. 1
(to Prospectus dated August 25, 2021)
INVESCO DB US DOLLAR INDEX TRUST
INVESCO DB US DOLLAR INDEX BULLISH FUND
This Prospectus Supplement No. 1 (Supplement No. 1) supplements and amends the Prospectus dated August 25, 2021 (the Prospectus), as may be supplemented from time to time.
Effective immediately, the following is added to the Summary Information Risk Factors section beginning on page 2 of the Prospectus:
| Following Russias invasion of Ukraine in late February 2022, various countries, including the United States, issued broad-ranging economic sanctions against Russia and Belarus. Such sanctions, and impacts from the conflict and related events, may result in increased volatility in the value of DX Contracts and may have an adverse effect on the performance of the Fund and value of the Shares. |
In addition, the following disclosure is added to the Risk Factors section beginning on page 12 of the Prospectus:
Risk that Russias Invasion of Ukraine May Result in Market Volatility that Could Adversely Affect the Funds Performance.
Following Russias invasion of Ukraine in late February 2022, various countries, including the United States, Australia, Canada, the United Kingdom, Switzerland, Germany, France, and Japan, as well as NATO and the European Union, issued broad-ranging economic sanctions against Russia and Belarus. The resulting sanctions (and potential further sanctions in response to continued military activity), the potential for military escalation and other corresponding events, have had, and could continue to have, severe negative effects on regional and global economic and financial markets, including increased volatility, reduced liquidity and overall uncertainty. Russia may take additional counter measures or retaliatory actions (including cyberattacks), which could exacerbate negative consequences on global financial markets. The duration of ongoing hostilities and corresponding sanctions and related events cannot be predicted. Impacts from the conflict and related events may result in increased volatility in the value of DX Contracts and may have an adverse effect on the performance of the Fund and value of the Shares.
The Shares trade on the NYSE Arca under the symbol UUP.
Investing in the Shares involves significant risks. See RISK FACTORS starting on page 12 of the Prospectus.
These securities have not been approved or disapproved by the Securities and Exchange Commission or any state securities commission nor has the Securities and Exchange Commission passed upon the adequacy or accuracy of the Prospectus or this Prospectus Supplement No. 1. Any representation to the contrary is a criminal offense.
The Fund is not a mutual fund or any other type of investment company within the meaning of the Investment Company Act of 1940, as amended, and is not subject to regulation thereunder.
THE COMMODITY FUTURES TRADING COMMISSION HAS NOT PASSED UPON THE MERITS OF PARTICIPATING IN THIS POOL NOR HAS THE COMMISSION PASSED ON THE ADEQUACY OR ACCURACY OF THIS DISCLOSURE DOCUMENT.
The date of this Prospectus Supplement No. 1 is May 10, 2022.
PLEASE RETAIN THIS SUPPLEMENT FOR FUTURE REFERENCE
P-UUP-PRO-1-SUP-1 051022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Compass Minerals International, Inc. (CMP)
- ROSEN, A LEADING NATIONAL FIRM, Encourages Sharecare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SHCR
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!